Bliddal H, Bays H, Czernichow S, et al
Absolute contraindications: Personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN2), known hypersensitivity to semaglutide or any excipient Relative contraindications: History of pancreatitis, severe gastrointestinal disease (gastroparesis, inflammatory bowel disease), current pregnancy or planned pregnancy within 2 months, history of suicidal ideation or major depressive disorder (monitor closely) Use with caution: Patients on insulin or sulfonylureas (hypoglycemia risk), patients with diabetic retinopathy (risk of transient worsening), patients with renal impairment (adjust monitoring) Pre-Treatment Workup Thorough semaglutide training for physicians includes a standardized pre-treatment assessment protocol
We empower life sciences with connected intelligence, transforming data into actionable insights for smarter decisions and better patient outcomes
Practice-Changing Developments in Stage III Melanoma: Surgery, Adjuvant Targeted Therapy, and Immunotherapy